Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting-Reference-Cited by-同舟云学术

Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting

Published:2018-12 Issue:12 Volume:93 Page:1213-1219
ISSN:1552-4922
Container-title:Cytometry Part A
language:en
Short-container-title:Cytometry

Author:

Fehm Tanja N.¹,Meier‐Stiegen Franziska¹,Driemel Christiane²,Jäger Bernadette¹,Reinhardt Florian¹,Naskou Johanna¹,Franken André¹,Neubauer Hans¹,Neves Rui P.L.²,Dalum Guus²,Ruckhäberle Eugen¹,Niederacher Dieter¹,Rox Jutta M.³,Fischer Johannes C.³,Stoecklein Nikolas H.²

Affiliation:

1. Department of Obstetrics and Gynecology, Faculty of the Heinrich‐HeineUniversity Hospital and Medical Faculty, University Düsseldorf, Düsseldorf, North Rhine‐Westphalia Germany

2. Faculty of the Heinrich‐Heine, General, Visceral and Pediatric SurgeryUniversity Hospital and Medical Faculty, University Düsseldorf, Düsseldorf, North Rhine‐Westphalia Germany

3. Faculty of the Heinrich‐Heine, Institute for Transplantation Diagnostics and Cell TherapeuticsUniversity Hospital and Medical Faculty, University Düsseldorf, Düsseldorf, North Rhine‐Westphalia Germany

Funder

Terumo BCT

Innovative Medicines Initiative

Seventh Framework Programme

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.a.23669

Reference18 articles.

1. Pros: Can tissue biopsy be replaced by liquid biopsy?